Abogen is a platform-based biotechnology company based on mRNA drugs. Through mRNA instructions, the human body becomes a processing factory for protein drugs needed by itself to achieve the purpose of curing diseases. The company's pipeline covers a variety of oncology drugs and infectious disease vaccine products. Abogen was established in 2019 and is located in Suzhou Industrial Park.
| Website | http://www.abogenbio.com/ |
| Employees | 60 (59 on RocketReach) |
| Founded | 2019 |
| Address | building b1 no.218 Xinghu Street Suzhou Industrial Park Unit 501, Suzhou, Jiangsu 215123, CN |
| Phone | +86 20 7939 1665 |
| Industry | Pharmaceutical Manufacturing, Business Services General, Biotechnology, Business Services, Drug Discovery |
| Keywords | Mrna Therapeutics, Rna Therapeutics, Platform Technology, Biotechnology, Biotech, Pharmaceutical Development, Gene Therapy, Drug Discovery, Pharmaceutical Research, Protein Therapeutics, Drug Manufacturing, Genetic Medicine, Molecular Medicine, Biologics, Immunotherapy, Clinical Trials, Oncology, Rare Diseases |
| Competitors | Johnson & Johnson, Roche, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Moderna Therapeutics, Novavax, CureVac +46 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Suzhou Abogen Biosciences employee's phone or email?
Bo Y. is the CEO of Suzhou Abogen Biosciences.
59 people are employed at Suzhou Abogen Biosciences.
Suzhou Abogen Biosciences is based in Suzhou, Jiangsu.
The NAICS codes for Suzhou Abogen Biosciences are [54, 541].
The SIC codes for Suzhou Abogen Biosciences are [873, 87].